Search Results - "Minartz, C"

Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany by Lux, M.P., Minartz, C., Müller-Huesmann, H., Sandor, M.F., Herrmann, K.H., Radeck-Knorre, S., Neubauer, A.S.

“…•Gene expression tests have a high impact on the total value of breast cancer treatment.•Oncotype DX test can help to avoid unnecessary chemotherapy and…”
Get full text

Price Negotiation For Pharmaceuticals in Germany: High Influence Of Eu Price Weighting Method by Neubauer, A.S, Voss, P, Minartz, C, Gmeiner, A, Neubauer, G

Get full text

POSC206 How Gene Therapy for Rare Diseases Differs from Chronic Therapy: The Case of AADC-Deficiency by Boehnke, A, Minartz, C, Radeck, S, Neubauer, A

Get full text

Kosten und Nutzen der Darmkrebsprävention by Neubauer, G., Minartz, C.

“…Zusammenfassung Die Darmkrebsprävention rettet Leben und ist darüber hinaus auch aus ökonomischen Gesichtspunkten positiv zu bewerten. Anhand eines…”
Get full text

PCV47 Burden of Disease and Social IMPACT of Myocardial Infarction and Ischemic Stroke in Germany from 2018 until 2030 by Dornstauder, E., Sidelnikov, E., Minartz, C., Niedermeier, C., Neubauer, G.

Get full text

PCN97 Budget IMPACT of Oncotype DX GPS ASSAY in Patients with Localized Prostate Cancer in Germany by Tilki, D., Minartz, C., Herrmann, K., Kenny, K., Neubauer, A.

Get full text

1126P Budget impact of Oncotype DX test compared to further gene expression tests in patients with early breast cancer in Germany by Lux, M.P., Minartz, C., Müller-Huesmann, H., Sandor, M-F., Herrmann, K.H., Radeck-Knorre, S., Neubauer, A.S.

Get full text

PCN66 DISCRETE EVENT SIMULATION MODEL OF MOR208 IN COMBINATION WITH LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA by Neubauer, A., Minartz, C., Schwenke, C., Kurukulasuriya, N., Boehnke, A.

Get full text

PHP269 - Quality Assured Use of Pharmaceuticals: Does German Gba Follow Ema? by Menzler, Jzzz, Minartz, C, Thienel, P, Neubauer, AS

Get full text

Quality Assured Use of Pharmaceuticals: Does German Gba Follow Ema? by Menzler, Jzzz, Minartz, C, Thienel, P, Neubauer, AS

“…OBJECTIVES: After receiving the EMA approval for Europe, it is mandatory for pharmaceuticals in Germany to complete the AMNOG process to receive reimbursement…”
Get full text

Cost-effectiveness of early treatment of ACPA-positive rheumatoid arthritis patients with abatacept by Neubauer, Aljoscha S, Minartz, Christof, Herrmann, Kirsten H, Baerwald, Christoph G O

“…Studies have reported that the presence of elevated anti-citrullinated protein antibodies (ACPA)/RF levels, together with joint erosions, is associated with…”
Get full text

PHP144 - Price Negotiation For Pharmaceuticals in Germany: High Influence Of Eu Price Weighting Method by Neubauer, A.S., Voss, P, Minartz, C., Gmeiner, A., Neubauer, G.

Get full text

Economic Short-Term Cost Model for Stereotactic Radiotherapy of Neovascular AMD by Neubauer, A S, Reznicek, L, Minartz, C, Ziemssen, F

“…Stereotactic radiation therapy (Oraya, OT) is available as a second line therapy for patients who, despite intensive anti-VEGF therapy for neovascular AMD, do…”
Get more information